Woodford forced to write down values of holdings; Novartis showcases positive PhIII MS data
→ Neil Woodford‘s investment trust was forced to write down the value of one its holdings today by just under $40 million, another tumble in what’s become a long-running landslide for the once marquee firm. Once one of Britain’s most successful stock pickers and a prominent supporter of the nation’s biotech industry, Woodford has found himself in the crosshairs since he suspended the Equity Income Fund after years of underperformance and months of massive withdrawals. The name of the written-down holding is yet to be announced.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.